Vangala Ramakrishna

My name is Vangala Ramakrishna and I am writing this letter to apply for the position of Postdoctoral Researcher at your laboratory. I completed my Ph.D. dissertation entitled “Genetic mutations associated with injectable anti-tubercular second-line drugs in clinical isolates of Mycobacterium tuberculosis from North India.” at King George’s Medical University in May 2022. Currently, I am working as a research officer in the same laboratory.

I have a strong background in Microbiology, molecular biology, Virology & Bacteriology and for the past 9 years, I have been working in Virology and molecular biology (Grade-I, Virology) with an emphasis on diagnosis and genome-wide study, for my Ph.D. I have been working on Mycobacterium tuberculosis at the same time. In addition, I have also worked on 21 different types of viruses’ diagnosis and research. I have been working on various virus outbreaks like pandemicH1N1, and COVID-19.I was an author Co-author for different national and international journals with a good impact factor

I have a strong background in Microbiology, molecular biology & Bacteriology and for the past nine years I have been working at Virology and molecular biology with the emphasize of diagnosis and genome-wide study, for my Ph.D I have been working on Mycobacterium tuberculosis at the same time. My Ph.D., dissertation mainly discusses the prevalence and pattern of second line injectable drug resistance among newly diagnosed multi-drug resistant tuberculosis (MDR-TB) and extensively drug resistant (XDR) M. tuberculosis strains. We investigated the type and frequency of genetic mutations, as well as their association with second-line injectable drug’s (SLIDs) resistance. (Publication list is attached with the CV). In addition, I have also worked on 21 different types of viruses’ diagnosis and research. I have been working various virus outbreaks and pandemicH1N1, and COVID-19. During this period I was specially deal with genome sequencing of different viruses and bacteria using different flat forms like Sanger sequencing (3130, 3500Dx), Next generation sequencing (Ion Torrent),Oxford Nanopore for COVID-19 virus genotyping, we discovered a new genotype of hepatitis C virus which is uncommon in Indian population

Ph.D. (Microbiology Molecular Biology)
Thesis Supervisor: Dr.(Prof.) Amita Jain
King George’s Medical University, Lucknow, India
Thesis title: “Genetic mutations associated with injectable anti- tubercular second line drugs in clinical isolates of Mycobacterium tuberculosis from North India.”